Literature DB >> 17446871

Programming the next generation of dendritic cells.

Richard G Carroll1, Carl H June.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17446871      PMCID： PMC3809055          DOI： 10.1038/sj.mt.6300166

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  17 in total

1.  Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system.

Authors:  R Schroers; I Sinha; H Segall; I G Schmidt-Wolf; C M Rooney; M K Brenner; R E Sutton; S Y Chen
Journal:  Mol Ther       Date:  2000-02       Impact factor: 11.454

2.  Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response.

Authors:  Michael J Palmowski; Luciene Lopes; Yasuhiro Ikeda; Mariolina Salio; Vincenzo Cerundolo; Mary K Collins
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

3.  Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines.

Authors:  Richard C Koya; Takahiro Kimura; Antoni Ribas; Nora Rozengurt; Gregory W Lawson; Emmanuelle Faure-Kumar; He-jing Wang; Harvey Herschman; Noriyuki Kasahara; Renata Stripecke
Journal:  Mol Ther       Date:  2007-03-20       Impact factor: 11.454

4.  Autocrine stimulation after transfer of the granulocyte/macrophage colony-stimulating factor gene and autonomous growth are distinct but interdependent steps in the oncogenic pathway.

Authors:  C Laker; C Stocking; U Bergholz; N Hess; J F De Lamarter; W Ostertag
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agents.

Authors:  K A Candido; K Shimizu; J C McLaughlin; R Kunkel; J A Fuller; B G Redman; E K Thomas; B J Nickoloff; J J Mulé
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

6.  Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection.

Authors:  K Kaneko; Z Wang; S H Kim; A E Morelli; P D Robbins; A W Thomson
Journal:  Gene Ther       Date:  2003-01       Impact factor: 5.250

7.  Making dendritic cells from the inside out: lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14+ monocytes generates dendritic cells in vitro.

Authors:  Richard C Koya; Jeffrey S Weber; Nori Kasahara; Roy Lau; Maria C Villacres; Alexandra M Levine; Renata Stripecke
Journal:  Hum Gene Ther       Date:  2004-08       Impact factor: 5.695

8.  Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols.

Authors:  Melissa Dullaers; Karine Breckpot; Sonja Van Meirvenne; Aude Bonehill; Sandra Tuyaerts; Annelies Michiels; Lieven Straetman; Carlo Heirman; Catherine De Greef; Pierre Van Der Bruggen; Kris Thielemans
Journal:  Mol Ther       Date:  2004-10       Impact factor: 11.454

9.  Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage.

Authors:  R A Lang; D Metcalf; R A Cuthbertson; I Lyons; E Stanley; A Kelso; G Kannourakis; D J Williamson; G K Klintworth; T J Gonda
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

10.  Gene therapy of metastatic cancer by in vivo retroviral gene targeting.

Authors:  R K Hurford; G Dranoff; R C Mulligan; R I Tepper
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330
View more
  4 in total

Review 1.  Adoptive immunotherapy: good habits instilled at youth have long-term benefits.

Authors:  Chrystal M Paulos; Megan M Suhoski; Gabriela Plesa; Tianying Jiang; Samik Basu; Tatiana N Golovina; Shuguang Jiang; Nicole A Aqui; Daniel J Powell; Bruce L Levine; Richard G Carroll; James L Riley; Carl H June
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

2.  Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation.

Authors:  Bala Sai Sundarasetty; Stephan Kloess; Olaf Oberschmidt; Sonja Naundorf; Klaus Kuehlcke; Anusara Daenthanasanmak; Laura Gerasch; Constanca Figueiredo; Rainer Blasczyk; Eliana Ruggiero; Raffaele Fronza; Manfred Schmidt; Christof von Kalle; Michael Rothe; Arnold Ganser; Ulrike Koehl; Renata Stripecke
Journal:  J Transl Med       Date:  2015-07-22       Impact factor: 5.531

Review 3.  Lentivirus-Induced Dendritic Cells (iDC) for Immune-Regenerative Therapies in Cancer and Stem Cell Transplantation.

Authors:  Renata Stripecke
Journal:  Biomedicines       Date:  2014-08-21

Review 4.  Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation.

Authors:  Julia K Bialek-Waldmann; Michael Heuser; Arnold Ganser; Renata Stripecke
Journal:  Cancer Immunol Immunother       Date:  2019-10-18       Impact factor: 6.968
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.